New York biotech debuts, targeting dormant metastatic cancer cells - STAT

New York biotech debuts, targeting dormant metastatic cancer cells - STAT

STAT Plus: New York biotech debuts, targeting dormant metastatic cancer cells

By SHARON BEGLEY

ANNE WESTON/FRANCIS CRICK INSTITUTE/WELLCOME

HiberCell, which has raised roughtly $60 million, calls itself the first company exclusively focused on the detection and treatment of dormant tumor cells.

READ MORE